Executive Committee

Executive Committee

The Executive Committee (EC) provides strategic leadership and decision-making to guide CTTI’s direction and priorities. Comprising 16 distinguished U.S. and international thought leaders from academia, government, industry, and patient advocacy, the EC brings deep expertise in advancing healthcare and medical research. Members serve three-year terms, contributing their knowledge and vision to drive meaningful, evidence-based improvements in the design and conduct of clinical trials. 

Leadership

Mark McClellan

Mark B McClellan, MD, PhD

Chair

John Alexander, MD, MHS, FACC

Co-Chair

Dianne Paraoan, MPH

Interim Co-Chair

Members

 

Barbara E. Bierer, MD

 

 

Dana Lewis

 

Christina Brennan, MD

Virginia Nido

 

Dan M. Cooper, MD

 

Stephen Pyke

 

 

Rachael L. Fleurence, PhD, MSc

 

Joni L. Rutter, PhD

Morgan Hanger

Mokash (Moke) Sharma, MBA

Brad Hirsch, MD

Ana Zanoletty

Ana Zanoletty

 

 

Esther Krofah

 

Bram Zuckerman, MD

Emeritus Members

Susan Alpert, PhD, MD

Jodi Black, PhD

Robert Califf, MD

Donna R. Cryer, JD

Michael S Cuffe, MD, MBA

David DeMets, PhD

Hans-Georg Eichler, MD, MSc

Pat Furlong

Steven K. Galson, MD, MPH

Kenneth Getz, MBA

Dalvir Gill, PhD

Glenn Gormley, MD, PhD

Alberto Grignolo, PhD

John Hubbard, PhD, FCP

Kathy Hudson, PhD

Patricia Hurley, MSc

Louis Jacques, MD

Michael Kolodziej, MD

Richard Kuntz, MD, MSc

Michael Lauer, MD

Freda Lewis-Hall, MD

Theodore Lystig, PhD, MS

Rod MacKenzie, PhD

Deven McGraw, JD, MPH, LLM

Pierre Meulien, PhD

Briggs Morrison, MD

Garry Neil, MD

Janette Panhuis

Amy Patterson, MD

Richard Platt, MD, MS

Ed Ramos, PhD

Nancy Roach

CDR Melissa Robb

Jean Lucien Rouleau, MD

Joe Selby, MD, MPH

Rachel Sherman, MD, MPH, FACP

Jay Siegel, MD

Robert Temple, MD

Veronica Todaro, MPH

Spiros Vamvakas, MD

Tom Walley, CB